Akili Grabs CE Mark for Children’s Digital ADHD Treatment By Sam | June 22, 2020 The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter